Rockwell Medical, Inc. (DE) Common Stock (RMTI) — Analysis Summary
Rockwell Medical, Inc. (DE) Common Stock (RMTI) has a market cap of $22.22M with year-over-year revenue growth of -31.8%. Net margin stands at -7.7%. The stock trades at a P/E ratio of -4.1.
Key Takeaways
- Revenue changed -31.8% year-over-year
- Net margin of -7.7%
- P/E ratio of -4.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, RMTI posted revenue growth of -31.8% and trades at a P/E of -4.1.
Rockwell Medical, Inc. (DE) Common Stock (RMTI)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -4.3x — earnings do not cover interest payments
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
157
Headquarters
WIXOM, MI
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.